NCT00434967 - Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo | Biotech Hunter

Enrollment

2,207

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

Hypertension

Interventions

DRUG

Candesartan cilexetil

32 mg oral tablet

DRUG

Hydrochlorothiazide

25 mg oral tablet

DRUG

Candesartan/HCT 32/25 mg

Trial Locations (27)

Unknown

Research Site, Dour

Research Site, Gozée

Research Site, Hasselt

Research Site, Linkebeek

Research Site, Marchovelette

Research Site, Ronquières

Research Site, Saint-Médard

Research Site, Steenokkerzel

Research Site, Daugavpils

Research Site, Ogre

Research Site, Riga

Research Site, Gozo

Research Site, Gwardiamangia

Research Site, Arad

Research Site, Bucharest

Research Site, Iași

Research Site, Piteşti

Research Site, Ploieşti

Research Site, Târgovişte

Research Site, Timișoara

Research Site, Moscow

Research Site, Saint Petersburg

Research Site, Bratislava

Research Site, Levice

Research Site, Lučenec

Research Site, Prešov

Research Site, Šahy